Ivermectin D2
| Product Name | Ivermectin D2 |
|---|---|
| Alternate Names | Ivermectin Stable Isotopes, Stable Isotopes of Ivermectin |
| CAT No. | CS-O-06696 |
| CAS No. | 70288-86-7(Unlabeled) |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 877.11 g/mol |
| Mol. For. | C₄₈H₇₂D₂O₁₄ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Ivermectin |
| Canonical Smiles | CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C |
| InchIKey | AZSNMRSAGSSBNP-XPNPUAGNSA-N |
| Inchl | InChI=1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/b13-12+,27-15+,32-14+/t25-,26-,28-,30-,31-,33+,34-,35-,36-,37-,38-,39-,40+,41-,42-,43+,44-,45+,47+,48+/m0/s1 |
| IUPAC | (1R,4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6'-[(2S)-butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Ivermectin D2 is a derivative of Ivermectin, a medication used to treat various parasitic infections in both humans and animals. Ivermectin D2 is a semi-synthetic derivative of the original drug, which has shown greater efficacy and potency against parasitic infections in both pre-clinical and clinical studies.
The chemical structure of Ivermectin D2 is similar to that of Ivermectin, but it has a modified lactone ring that enhances its activity against parasites. Like its predecessor, Ivermectin D2 works by binding to the glutamate-gated chloride channel in the nervous system of parasites, causing paralysis and death.
Ivermectin D2 is used to treat a wide range of parasitic infections, including river blindness, strongyloidiasis, scabies, and lice infestations. It is also being studied for its potential to treat other diseases, such as COVID-19.
Ivermectin D2 is administered orally and is generally well-tolerated by patients. However, like any medication, it can cause side effects, such as nausea, dizziness, and headache. It is important to follow the prescribed dosage and duration of treatment to minimize the risk of side effects and ensure optimal effectiveness.
In conclusion, Ivermectin D2 is a potent and effective medication that has revolutionized the treatment of parasitic infections. It has the potential to play a significant role in the treatment of other diseases, and ongoing research is being conducted to explore its full potential.
Get an Instant Quote
Related Compounds
Ivermectin B1a-D2 | Ivermectin B1b-D2 |